Study drugs
SECONDARY, SCHISTOSOMIASIS
The anthelminthic drugs used in this trial were the WHO-approved medications for MDA of schistosomiasis and STH control, namely PZQ and ALB, respectively. The SMC drugs given were SP and AQ. The SMC drugs were obtained from the SMC implementation unit of the Senegal Ministry of Health, and albendazole and praziquantel were obtained from the NTD control programme of the Senegal Ministry of Health. Vitamin A and Zinc supplements were used as control drugs, so that the children randomized to all study arms received three drugs. Vitamin A and Zinc supplements have not been shown to affect the primary and secondary outcomes of this study [Doses of study medications